Sometimes leadership means making the tough cut so you can keep investing in the people and pieces that truly add value.

The seating market can be a tough nut to crack for newcomers.

As a registered dietitian, most of Maddie Pasquariello's Instagram feed looks like how you'd expect. Beautifully constructed salads, grain bowls, and fruit-topped oats. Occasionally, a more decadent ...

We’ve all been there—that moment when you realize you’re in way over your head. For me, it happened during my first briefing ...

Discover how Pareto efficiency optimizes resource allocation and explore its measurement along the production possibility ...

Catalyst Pharmaceuticals (CPRX) soared 19% after a report that Italian drugmaker Angelini Pharma is evaluating a potential purchase of the drugmaker. Angelini is working with advisers as it evaluates ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

Industry representatives, patients, and regulators shared their perspectives on the reforms to the EU pharmaceutical ...

MILAN, April 29 - Italy's family-owned Chiesi Group will buy U.S.-listed KalVista Pharmaceuticals (KALV.O), opens new tab in an all-cash deal valued at about $1.9 billion, the ‌two companies said on ...

The Boards of Directors of Angelini Pharma and Catalyst Pharmaceuticals have unanimously approved the acquisition of Catalyst Pharmaceuticals at 31.50 USD per share in cash, for a total consideration ...

With an eye on the lucrative U.S. market, Italy’s Angelini Pharma will acquire rare disease specialist Catalyst Pharmaceuticals and its potential blockbuster, Firdapse, for $4.1 billion. Rome-based ...

April 23 (Reuters) - The U.S. Food and Drug Administration has approved Regeneron's (REGN.O), opens new tab gene therapy ‌for a rare genetic form of deafness, the company said on Thursday. This ...